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Abstract
Background: To determine the extent to which members of the general population have talked to their physician
about their wishes regarding medical treatment at the end of life, to describe the prevalence of advance directives
on euthanasia, and to identify associated factors.
Method: This study used data from the cross-sectional Health Interview Study (HIS) 2008 that collected data from a
representative sample (N = 9651) of the Belgian population.
Results: Of all respondents, 4.4 % had spoken to their physician about their wishes regarding medical treatment at
the end of life, while 1.8 % had an advance directive on euthanasia. Factors positively associated with discussions
regarding wishes for medical treatment at the end of life were being female, being older in age, having poorer
health status and having more GP contacts. People older than 55 years and living in Flanders or Brussels were more
likely than the youngest age categories to have an advance directive on euthanasia.
Conclusion: Younger people, men, people living in the Walloon region of Belgium, people without a longstanding
illness, chronic condition or disability and people with few GP contacts could represent a target group for
education regarding advance care planning. Public information campaigns and education of physicians may help
to enable the public and physicians to engage more in advance care planning.
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Background
Advance care planning (ACP) has gained international
attention for its perceived benefits in enhancing patient
autonomy, ensuring better quality of care and improving
quality of life in the final stages of life [1, 2]. ACP is the
process through which patients are able to express their
preferences regarding end-of-life care [3, 4]. ACP in-
volves discussions about goals of care and preferences
for treatment between patients and health professionals,
which may involve family members or friends. ACP may
include the designation of a surrogate decision-maker to
make future health care decisions for the patient, or the
completion of an advance directive (AD) [5].
A recently published systematic review showed that
interventions including communication about ACP im-
proved the quality of communication and concordance
between patient preferences and end-of-life care re-
ceived [2]. Because of these benefits, ACP is seen as a
useful behaviour to promote among the general public
and in several countries public health campaigns to en-
courage it have been put in place such as the Speak Up
campaign in Canada or the Dying Matters initiative in
the UK [6, 7]. Nonetheless, little information is available
on the involvement of the general public in ACP and the
extent to which people actually plan their end-of-life
care, which is the focus of this population-based study
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of the Belgian general population. Improved understand-
ing of the public’s involvement in ACP could help in-
form the development of public policy. Determining
which subgroups of the population are engaged in ACP
and which are not can help to define the communication
and health campaigns about ACP within a context that
is meaningful to the public [8].
In Belgium the Law on Patients’ Rights (2002) gives
people the right to reject any medical treatment and to
appoint a surrogate decision-maker to advocate for their
rights if they are unable to make decisions or speak for
themselves [9]. Refusal of treatment can be documented
in a legally binding negative AD, also known as a living
will, which is similar to those in the Netherlands, the
USA and Canada. Furthermore, people can document in
advance specific wishes for end-of-life care in an ad-
vance statement, also called a positive AD, which is indi-
cative but not legally binding on the physician. These
advance statements are called “positive” ADs because
they are about what patients would still want if they
could no longer ask for themselves, as opposed to nega-
tive ADs to refuse treatments or examinations. Belgium
is a specific case as it recognizes a type of positive AD
that does not exist in most other countries. In 2002, the
Belgian Parliament legalised euthanasia, i.e. the use of
life-ending drugs by a physician on explicit patient re-
quest. People in Belgium can draft an AD on euthanasia
in case they find themselves in specific situations of lack
of capacity [10, 11]. The law on euthanasia allows people
with mental capacity to draw up a prior declaration of
intent to request euthanasia should they be in an irre-
versible state of unconsciousness and no longer able to
ask for euthanasia themselves. In practice, this means
that an AD on euthanasia only applies to those in an
irreversible coma. A request for euthanasia is not legally
binding and acts as a guide for the treating physician.
ADs on euthanasia may be registered at the city hall, but
this is not mandatory. In 2013, a total of 20,414 people
in Belgium registered an AD on euthanasia, an increase
compared with 12,728 people in 2012.
The aim of this study is firstly to determine to what
extent members of the general population have talked to
a physician about their wishes regarding medical treat-
ments at the end of life and what the prevalence is of an
AD on euthanasia in the general population and sec-
ondly to determine to what extent socio-demographic
characteristics, health status and health service use are
associated with the involvement in ACP.
Methods
Design and population
This study uses data from the cross-sectional Health
Interview Study (HIS) that collects data from a large
representative sample of the Belgian population. The
HIS is organized by the Belgian Scientific Institute of
Public Health (WIV-ISP) and was conducted for the
fourth time in 2008–2009. Around 6000 private house-
holds are randomly selected from the National Population
Register using a multistage stratified clustered sampling
process. Of each selected household, a maximum of four
members are eligible. The householder and partner are
always selected, as well as two extra randomly selected
members (or three if there is no partner). This study in-
cludes only participants older than 15 years.
Questionnaire
Involvement in ACP was analyzed based on two items:
(1) Have you ever spoken to your physician about your
wishes regarding medical treatments at the end of life?
and (2) Do you have an advance directive requesting
euthanasia?. Possible responses were Yes and No. Data
collection is performed via a self-administered question-
naire filled in by each selected person aged 15 years or
older. However, only respondents aged 18 years or older
are included in the analysis, because an advance direct-
ive on euthanasia can only be drafted by people older
than 18.
Several procedures were used to ensure data quality:
the content of the HIS questionnaire was discussed in
workgroup sessions with academic experts, health gov-
ernment agencies and fieldwork experts. The question-
naires were pre-tested: firstly, questions from other
European surveys that were added to the HIS 2008 ques-
tionnaire benefited from a large scale pre-test [12] and
secondly, the HIS questionnaire was pre-tested by the
WIV-ISP in a small, diverse sample of people to evaluate
the length, comprehension, readability etc. of questions.
Analysis
The selection of the independent variables is based
on their possible influence on involvement in ACP or
the formulation of ADs, as shown in previous re-
search [13–15]. Socio-demographic measurements in-
clude gender, age, educational level, marital status and
region of residence. Health-related measurements in-
clude health status (having a longstanding illness,
chronic condition or disability) and health service
utilization (mean number of GP contacts in the past
12 months and mean number of specialist contacts in
the past 12 months).
The sample is weighted according to the stratified
clustered sampling design of the survey to be representa-
tive of the Belgian population. Involvement in ACP is
described using frequencies. The independent character-
istics were tested for significant association with involve-
ment in ACP using Pearson chi2 test (not shown in
paper) and, when found significant, entered in multivari-
ate logistic regression models in order to control for
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confounding effects and investigate their association
with the dependent variables. Confidence intervals are
calculated at the 95 % level. Analyses are conducted with
SPPS 22.0 software using the complex samples proced-
ure to account for the complex survey design.
Ethical considerations
The protocol of the Belgian HIS 2008 is approved by the
Superior Council of Statistics [12]. Submisson to the
Ethical Committee of the WIV-ISP was not needed,
because it is a recurrent project that had been approved
in 2004. Providing the data by the participants involved
giving implied consent (not written).
Results
The participation rate among the contacted households
was 55 % (around 6,000 households were contacted). Of
the 9651 respondents, 52.1 % were female, 26.2 % were
between the ages of 18 and 34, 37.5 % were between the
ages of 35 and 54, 25.6 % between 55 and 74 and 10.7 %
75 years or older (Table 1). For 38.7 % of the respon-
dents the highest educational level within the household
was higher education (post-secondary). More than half
of the respondents were married or had a registered civil
relationship (56.6 %) and lived in Flanders (58.3 %). Of
all respondents 32.7 % suffered from a longstanding
illness, chronic condition or disability. Around a quarter
had seen their GP once every two months in the last
year and the majority had not seen a specialist in the
past 12 months (77.5 %).
Involvement in advance care planning
Of all respondents, 4.4 % indicated they had talked to a
physician regarding medical treatments at the end of life
and 1.8 % said they had an AD on euthanasia (Table 1).
Of all respondents who had discussed their wishes re-
garding medical treatment at the end of life with a phys-
ician, 22.2 % had an AD on euthanasia. Vice versa,
55.4 % of all respondents who had an AD on euthanasia,
had discussed their wishes regarding medical treatment
at the end of life with a physician. Women, older per-
sons, the widowed and people who suffer from a long-
standing illness, chronic condition or disability had
spoken more often about their wishes regarding medical
treatment at the end of life, as had those who saw a GP
or specialist more than once a month. Having an AD on
euthanasia was also more common among older respon-
dents, the widowed and people with a longstanding ill-
ness, chronic condition or disability. Remarkably, people
with a lower educational level had spoken more with a
physician about medical treatments at the end of life
and had more often an AD on euthansia than people
with a higher educational level. However, a crosstabula-
tion between age and educational level showed that the
majority of older people were represented in the lowest
educational levels, while the majority of younger had a
higher educational level (not shown in the paper).
Factors associated with involvement in advance care
planning
The probability of having spoken to a physician about
wishes regarding medical treatments at the end of life
was higher for women (OR = 1.5) and those with a
longstanding illness, chronic condition or disability
(OR = 1.5) (Table 2). The probability of having discussed
their wishes with a physician also significantly increased
with age and with the number of GP contacts.
Compared with the youngest age category, people
older than 55 years were more likely to have an AD on
euthanasia. Those living in the Walloon region of
Belgium were less likely to have an AD on euthanasia
compared with those living in Flanders (OR = 0.5).
Discussion
This study shows that 4.4 % of a representative sample
of the Belgian general public have spoken about their
wishes regarding medical treatments at the end of life,
while 1.8 % have an AD on euthanasia. Discussions with
a physician regarding wishes for medical treatment at
the end of life were more likely to have taken place
among women, as people get older, among people with a
poorer health status and those having more GP contacts.
Having an AD on euthanasia was more likely for people
older than 55 years and living in Flanders or Brussels.
Discussions regarding wishes for medical treatment at
the end of life with physicians are relatively rare among
the Belgian general public. Even among those who have
an AD on euthanasia only half of respondents (55.4 %)
had discussed their wishes regarding medical treatment
with a physician. However, an AD on euthanasia does
not need to be discussed with a physician, something
about which some people might be hesitant. An AD on
euthanasia must be drafted in the presence of two adult
witnesses and they are responsible for notifying the
treating physician of its existence should the patient fall
into an irreversible coma. People can choose either to
deliver copies of their AD on euthanasia to a number of
people (of whom their physician might be one) or to
register it at the city hall in a federal database, but this is
not mandatory. It is however also possible that people
do visit their physician with the intention of discussing
the completion of an AD on euthanasia, but that the
physician omits to take up the opportunity to elaborate
on their wishes for medical treatment at the end of life.
A cross-sectional survey in the Netherlands (one of
the three countries, with Belgium and Luxembourg,
where euthanasia has been legal since 2002) showed that
13 % of the general population had discussed issues
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Table 1 Participant characteristics of the sample of the Belgian general population (N = 9651) and proportions having spoken about
wishes regarding medical treatments at the end of life with their physician and having an AD on euthanasia
Unweighted sample
(Weighted %)
Has spoken about wishes
regarding medical treatment
at the EOL to their physician
Has an AD on
euthanasia
N (%) % %
Total respondents 4.4 1.8
Socio-demographic factors
Gender Man 4244 (47.9) 3.3* 1.7
Woman 5080 (52.1) 5.4* 1.8
Age 18-34 2222 (26.2) 0.7* 0.5*
35-54 2906 (37.5) 3.5* 0.9*
55-74 2216 (25.6) 6.8* 3.3*
75+ 1980 (10.7) 12.0* 4.6*
Highest educational level within
the household
≤ Primary education 1437 (12.2) 6.7* 2.7
Lower secondary 1511 (15.9) 5.9* 1.8
Higher secondary 2770 (33.2) 4.8* 2.0
Higher education 3302 (38.7) 2.9* 1.4
Marital status Single (never married) 2399 (26.4) 2.0* 1.1*
Married or registered civil relationship 4672 (56.6) 3.9* 1.7*
Widow/er (not remarried) 1428 (8.2) 13.0* 4.5*
Divorced (not remarried) 804 (8.7) 7.3* 1.7*
Region of residence Flemish region 3304 (58.3) 3.8* 2.0*
Brussels’ region 2750 (10.6) 4.8* 2.5*




Yes 3437 (32.7) 7.8* 2.6*
No 5857 (67.3) 2.7* 1.4*
Health service use
Number of GP contacts Never 4502 (53.2) 2.1* 1.1*
1×/2 months 2447 (26.9) 5.2* 2.0*
1×/month 1412 (12.5) 8.5* 3.2*
≥1×/month 811 (7.4) 11.8* 3.0*
Number of specialist contacts Never 6930 (77.5) 3.6* 1.6
1×/2 months 1384 (14.4) 6.3* 1.8
1×/month 496 (5.1) 7.3* 3.9
≥1×/month 302 (3.0) 10.6* 2.4
Involvement in ACP
Has spoken about wishes
regarding medical treatments
at the EOL to their physician
412 (4.4) - 22.2*
Has an AD on euthanasia 167 (1.8) 55.4* -
Abbreviations: GP general practitioner, EOL end of life
Sums may not always amount to the total sample number because of missing values on variables. Percentages may not always add up to 100 because of
rounding. Percentages are row percentages
Missing values: for gender n = 0, age n = 0, for highest educational level in the household n = 304 (3.3 %); for marital status n = 21 (0.2 %); for region of residence
n = 0; for having a longstanding illness, chronic condition or handicap n = 30 (0.3 %); number of GP contacts n = 152 (1.6 %); number of SP contacts n = 212
(2.3 %); for having spoken about wishes regarding medical treatments at the EOL to their physician n = 2109 (22.6 %); for having an AD on euthanasia
n = 2128 (22.8 %)
* Significant at p <0.05 using Pearsons Chi2 test
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related to medical decision-making at the end of life
with a physician [13]. It is known that, especially in the
Netherlands, patients prioritize autonomy and control
during the dying process [16]. Cross-country studies also
repeatedly found that Dutch physicians discuss end-of-
life issues more frequently than their European counter-
parts [17–19]. Of the Dutch general population, 3 %
reported they have an AD on euthanasia compared with
1.8 % in the present study. Internationally, the interest of
people in making ADs refusing medical treatments
has been shown to be low, ranging between 18 % and
34 % in the general population of the USA [20–23]
and between 3 % and 19 % in the general population
in Europe [14, 24].
A number of characteristics associated with the pub-
lic’s engagement in ACP are consistent with earlier stud-
ies. Women and those with a serious illness or increased
dependency have been shown to discuss their end-of-life
care preferences more often with physicians or have
higher AD completion rates [13, 14, 20, 25]. As may be
expected, older people were also more likely to have
discussed or documented their end-of-life care wishes
than those in the youngest age categories [13, 26]. On
the one hand, evidence suggests that people in general
are unwilling to engage in ACP until they grow older or
become ill; a lack of information, procrastination or
avoidance could be important reasons for the low com-
pletion rates among younger people [27, 28]. Younger
people in good health tend not to feel the need for ACP.
On the other hand, physicians are also hesitant to initi-
ate these discussions and often believe that ACP is
unnecessary for young and healthy patients which com-
pounds these barriers [29, 30]. And although those who
have been widowed are more involved in the process of
ACP, marital status was surprisingly not a predictor of
engagement in ACP in this study [31]. A population-
based study on AD completion in Alberta showed that
people who had looked after or given care to a dying
person were more likely to complete an AD [32]. The
authors argue that experience of death and dying are
likely to have a greater impact on having an AD than
socio-demographic characteristics. In our study, older
age was a notable predictor of AD completion, but
experiences with death and dying were not asked
about. Older people, who are in general more likely
to be widowed, could have experienced a death in
their close environment. Also, the specific type of AD
examined in this survey was an AD on euthanasia as
opposed to an AD for medical treatment. Possibly,
lived experiences could also greatly influence the level
Table 2 Factors associated with involvement in ACP of a representative sample of the Belgian general population
OR (95 % CI) for yes vs. no*
Spoken about wishes regarding medical
treatments at EOL to physician
Having an advance directive
requesting euthanasia
Socio-demographic characteristics
Gender Man (ref) Ref
Woman 1.5 [1.1–2.0]
Age 18-34 (ref) Ref Ref
35-54 5.1 [2.6–9.9] 2.1 [0.8–5.1]
55-74 8.2 [4.1–16.4] 6.4 [2.7–14.9]
75+ 11.1 [5.2–24.0] 6.3 [2.1–18.4]
Region of residence Flemish region (ref) Ref
Brussels’ region 1.5 [0.9–2.4]
Walloon region 0.5 [0.3–0.9]
Health status





Number of GP contacts Never (ref) Ref
1×/2 months 1.7 [1.1–2.6]
1×/month 2.2 [1.3–3.5]
≥1×/month 3.0 [1.7–5.2]
Abbreviations: OR odds ratio, ref reference category, Ns not significant
*Odds Ratio with 95 % confidence interval from complex multivariate logistic regression analysis
Bold denotes significant at p < .05
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of involvement in ACP in Belgium. This is a focus for
future research.
Remarkably, people living in the Walloon region of the
country were less likely to have an AD on euthanasia
compared to people living in the Flemish part of
Belgium. Unfortunately, reasons for the identified differ-
ences between the regions in Belgium could not be ex-
plored. Previous research on end-of-life care in Belgium
has suggested a difference in medical culture between
the Dutch-speaking and French-speaking community,
with a stronger appreciation of curative, technological
and specialist medicine in the French-speaking commu-
nity [33]. Perhaps, societal or culturally determined atti-
tudes towards euthanasia might also differ between the
regions in Belgium and influence the prevalence of an
AD on euthanasia. However, these hypotheses need
more research before solid conclusions can be drawn.
This study also shows that having more contact with a
GP was associated significantly with discussion of end-
of-life care wishes. In the Belgian health care system a
strong emphasis is put on primary care and most people
have a long-lasting relationship with their GP whom they
consult regularly (78 % at least once a year) [34]. More-
over, the number of GP contacts increases exponentially
with age (and probably health-related problems) and per-
sons aged 75 or over are seen by their GP on an almost
monthly basis. Future interventions might focus on stimu-
lating GPs to initiate ACP discussions in good time as a
sudden or serious chronic illness can render any adult in-
capable of decision-making. The aim of interventions
should not only be to encourage the formulation of ADs
on euthanasia, as such ADs only apply to very specific
medical circumstances as described in the introduction,
but to provide adequate information about the different
types of ADs to those who are interested and to make the
process of completing an AD an opportunity to have im-
portant conversations with physicians, family and friends.
Even though a previous study has shown that the ma-
jority of people in Belgium are open to discussions on
end-of-life care [35], only a small percentage of the
population had discussed their wishes regarding medical
treatment at the end of life with a physician. This sug-
gests that the stimulation of both patients and physi-
cians to engage in end-of-life care discussions would be
useful to enhance ACP in practice. Public information
campaigns can increase awareness among the Belgian
general public regarding the importance of timely ACP
discussions. This study shows that younger people, men,
those living in the Walloon region of Belgium and those
with few GP contacts are a target group for education.
Nonetheless, older people represent another key target
group, as they are at higher risk of needing end-of-life
care [32]. Of those older than 75 years, only 12 % had
ever had a discussion with their physician about their
wishes regarding medical treatment at the end of life.
And although guidelines suggest that ACP should be
initiated with people who suffer from a chronic, life-
limiting illness, our results show that only 7.8 % of
people with a poorer health status had ever spoken with
a physician about their wishes for medical treatment at
the end of life. Public information campaigns can help to
overcome important barriers to engagement in ACP, in-
cluding the perception that ACP is irrelevant or the pos-
session of insufficient information to engage in such
discussions [5, 28]. Secondly, a more active role for the
physician in initiating such discussions could also en-
hance ACP. It has been suggested before that physicians
have the responsibility to inform their patients and to
initiate discussions in a timely manner [4, 36, 37]. How-
ever, they need to be trained and supported in how to
do this, they often delay communication until the end of
life or wait for patients to raise the topic [38–40].
This is the first study on the general public’s involve-
ment in ACP in Belgium. It is a population-based study
founded on a representative sample of the Belgian popu-
lation. Other important strengths include the large sam-
ple size, the robustness of the methodology and the
quality of research procedures. We used data from the
HIS, which has a long history of data collection in the
Belgian population and is not based only on a specific
interest in end-of-life care. However, this study also has
some limitations. Firstly, the specific context of Belgium
as one of the three countries where euthanasia is legal,
might hamper the generalizability of our results to other
settings. Secondly, because of the low response-rate
(55 %), non-response bias cannot be excluded. The miss-
ing values for the outcome variables are around 23 %
and non-response analysis showed that missing values
were more likely to be male, older, have a lower educa-
tional level and live in Wallonia or Brussels. As a result,
it is possible that some of our findings are biased because
of non-response. Thirdly, because this study examined the
respondent’s own report of their involvement in ACP, the
results may be subject to recall bias.
Conclusion
Few people in Belgium have discussed their wishes
regarding medical treatment at the end of life with their
physician or have completed an AD on euthanasia.
Younger people, men, people living in the Walloon re-
gion of Belgium, people without a longstanding illness,
chronic condition or disability and people with few GP
contacts might represent a target group for education as
they are less likely to engage in ACP. Public information
campaigns and the education of physicians may encour-
age the public to engage in ACP and help to enable
patients, families and physicians to have more conversa-
tions about care at the end of life.
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